Cui and coworkers conjugated the anti-cancer drug paclitaxel with iRGD to generate a self-assembling peptide paclitaxel-iRGD, and next, they encapsulated CD47 antibodies to produce a hydrogel (aCD47/PF). This evidence concerns the gene CD47 and cancer.